Ceftriaxone controlled release - MannKind Corporation/Sensile Medical
Alternative Names: Cephalosporin antibiotic micropump patch - MannKind Corporation; scCeftriaxoneLatest Information Update: 10 Dec 2025
At a glance
- Originator scPharmaceuticals
- Developer MannKind Corporation
- Class Antibacterials; Cephalosporins; Small molecules; Urinary anti-infective agents
- Mechanism of Action Cell wall inhibitors
-
Orphan Drug Status
No
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Phase II/III Bacterial infections
Most Recent Events
- 31 Dec 2021 ScPharmaceuticals files an IND application for Bacterial infections, prior to December 2021
- 31 Dec 2021 Adverse events data from a phase II/III trial in Bacterial infections (In volunteers) released by scPharmaceuticals (SC)
- 31 Dec 2021 Pharmacodynamics data from preclinical studies in Bacterial infections released by ScPharmaceuticals